MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
ABSTRACT Aims Current metabolic syndrome (mets) criteria often lack consideration for age and gender differences. This study introduces the mets‐Z score, a novel tool designed to enhance mets assessment and improve long‐term outcome predictions. Materials and Methods The mets‐Z score was developed u...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Journal of Diabetes Investigation |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jdi.70004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | ABSTRACT Aims Current metabolic syndrome (mets) criteria often lack consideration for age and gender differences. This study introduces the mets‐Z score, a novel tool designed to enhance mets assessment and improve long‐term outcome predictions. Materials and Methods The mets‐Z score was developed using principal component analysis (PCA) to weight five mets indicators—waist circumference, blood glucose, blood pressure, high‐density lipoprotein (HDL) cholesterol, and triglycerides—by gender and age. Data from 188,739 Taiwan Biobank participants, stratified by gender and age groups (20–39, 40–54, 55–64, 65+ years), were analyzed. Predictive performance for type 2 diabetes mellitus onset was assessed over a 4‐ to 5‐year follow‐up. Results The mets‐Z score achieved superior accuracy in predicting type 2 diabetes mellitus onset, with an AUC of 0.76 in men and 0.80 in women, significantly outperforming conventional indices (P < 0.0001). Conclusions By integrating age‐ and gender‐specific variations, the mets‐Z score provides a more personalized and precise tool for assessing metabolic and diabetes risk, surpassing existing methods. The tool is available for public use at http://bioinfolab.nhri.edu.tw/metsz/, supporting broader applications in precision medicine. |
|---|---|
| ISSN: | 2040-1116 2040-1124 |